Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lung Diseases, Interstitial | 50 | 2024 | 918 | 8.830 |
Why?
|
Idiopathic Pulmonary Fibrosis | 21 | 2024 | 514 | 4.870 |
Why?
|
Pulmonary Fibrosis | 14 | 2024 | 505 | 2.770 |
Why?
|
Mucin-5B | 12 | 2024 | 148 | 2.560 |
Why?
|
Lung | 50 | 2024 | 9979 | 2.230 |
Why?
|
Respiratory System Abnormalities | 4 | 2023 | 67 | 1.930 |
Why?
|
Pulmonary Emphysema | 9 | 2021 | 683 | 1.700 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 16 | 2024 | 3201 | 1.260 |
Why?
|
Tomography, X-Ray Computed | 49 | 2024 | 20588 | 1.220 |
Why?
|
Polymorphism, Genetic | 5 | 2017 | 4243 | 0.830 |
Why?
|
Asthma | 15 | 2011 | 6230 | 0.820 |
Why?
|
Smoking | 16 | 2024 | 9055 | 0.770 |
Why?
|
Immunoglobulin E | 7 | 2011 | 1505 | 0.770 |
Why?
|
Respiratory Function Tests | 13 | 2024 | 1685 | 0.740 |
Why?
|
Spirometry | 8 | 2024 | 928 | 0.700 |
Why?
|
Genetic Predisposition to Disease | 20 | 2024 | 17897 | 0.670 |
Why?
|
Hernia, Hiatal | 1 | 2020 | 90 | 0.670 |
Why?
|
Emphysema | 1 | 2021 | 238 | 0.640 |
Why?
|
Promoter Regions, Genetic | 8 | 2019 | 5773 | 0.600 |
Why?
|
Polymorphism, Single Nucleotide | 19 | 2024 | 15920 | 0.590 |
Why?
|
Solitary Pulmonary Nodule | 2 | 2019 | 279 | 0.590 |
Why?
|
Bronchiectasis | 3 | 2023 | 139 | 0.530 |
Why?
|
Forced Expiratory Volume | 8 | 2024 | 1813 | 0.510 |
Why?
|
Galectin 3 | 1 | 2016 | 240 | 0.470 |
Why?
|
Lung Diseases | 7 | 2023 | 1910 | 0.460 |
Why?
|
Disease Progression | 9 | 2024 | 13511 | 0.440 |
Why?
|
Lung Neoplasms | 9 | 2024 | 13386 | 0.430 |
Why?
|
Gastroesophageal Reflux | 1 | 2020 | 821 | 0.430 |
Why?
|
Costa Rica | 7 | 2010 | 180 | 0.420 |
Why?
|
Iceland | 4 | 2020 | 184 | 0.390 |
Why?
|
Sex Characteristics | 4 | 2015 | 2640 | 0.390 |
Why?
|
Humans | 126 | 2024 | 761222 | 0.370 |
Why?
|
Pyroglyphidae | 2 | 2008 | 89 | 0.370 |
Why?
|
Receptors, Interleukin-17 | 1 | 2011 | 82 | 0.360 |
Why?
|
Antifibrinolytic Agents | 1 | 2014 | 287 | 0.360 |
Why?
|
Family | 4 | 2020 | 3192 | 0.350 |
Why?
|
Total Lung Capacity | 4 | 2015 | 148 | 0.350 |
Why?
|
Male | 85 | 2024 | 360703 | 0.350 |
Why?
|
Matrix Metalloproteinase 12 | 1 | 2009 | 44 | 0.340 |
Why?
|
Female | 88 | 2024 | 392552 | 0.330 |
Why?
|
Interleukin-13 | 2 | 2011 | 392 | 0.320 |
Why?
|
Cytokines | 4 | 2012 | 7386 | 0.320 |
Why?
|
Pyridones | 1 | 2014 | 809 | 0.310 |
Why?
|
Aged | 47 | 2024 | 169292 | 0.300 |
Why?
|
Referral and Consultation | 1 | 2021 | 3608 | 0.300 |
Why?
|
Antigens, Dermatophagoides | 1 | 2008 | 98 | 0.300 |
Why?
|
Malaria | 1 | 2017 | 1225 | 0.300 |
Why?
|
Telomere | 3 | 2022 | 939 | 0.300 |
Why?
|
Cockroaches | 1 | 2008 | 97 | 0.290 |
Why?
|
Ascaris lumbricoides | 1 | 2007 | 10 | 0.290 |
Why?
|
Genome-Wide Association Study | 13 | 2023 | 12676 | 0.290 |
Why?
|
Middle Aged | 55 | 2024 | 220858 | 0.290 |
Why?
|
Cohort Studies | 21 | 2022 | 41496 | 0.280 |
Why?
|
Carbon Monoxide | 3 | 2019 | 547 | 0.270 |
Why?
|
Longitudinal Studies | 10 | 2024 | 14610 | 0.260 |
Why?
|
Indoles | 1 | 2014 | 1830 | 0.260 |
Why?
|
Pleura | 2 | 2017 | 244 | 0.260 |
Why?
|
Genetic Testing | 2 | 2021 | 3537 | 0.250 |
Why?
|
Asbestos | 2 | 2017 | 251 | 0.250 |
Why?
|
Bronchopulmonary Sequestration | 1 | 2005 | 43 | 0.250 |
Why?
|
Logistic Models | 7 | 2019 | 13249 | 0.250 |
Why?
|
Arthritis, Rheumatoid | 4 | 2024 | 3753 | 0.230 |
Why?
|
Vital Capacity | 5 | 2024 | 970 | 0.230 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 2 | 2024 | 1221 | 0.230 |
Why?
|
Hypersensitivity | 4 | 2011 | 1167 | 0.230 |
Why?
|
Hypersensitivity, Immediate | 1 | 2007 | 348 | 0.230 |
Why?
|
Enzyme Inhibitors | 1 | 2014 | 3702 | 0.220 |
Why?
|
Allergens | 3 | 2008 | 1433 | 0.220 |
Why?
|
Prevalence | 10 | 2023 | 15721 | 0.210 |
Why?
|
Aging | 2 | 2021 | 8702 | 0.210 |
Why?
|
Interleukin-10 | 1 | 2008 | 1176 | 0.200 |
Why?
|
Eosinophilia | 1 | 2007 | 557 | 0.200 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2016 | 8998 | 0.200 |
Why?
|
Proportional Hazards Models | 8 | 2022 | 12474 | 0.190 |
Why?
|
Myositis | 1 | 2024 | 270 | 0.190 |
Why?
|
Phenotype | 5 | 2021 | 16575 | 0.190 |
Why?
|
Pulmonary Alveoli | 3 | 2019 | 651 | 0.190 |
Why?
|
Age Factors | 7 | 2021 | 18384 | 0.190 |
Why?
|
Survival Rate | 6 | 2021 | 12728 | 0.190 |
Why?
|
Adrenal Cortex Hormones | 2 | 2009 | 1878 | 0.190 |
Why?
|
Genotype | 7 | 2019 | 12985 | 0.190 |
Why?
|
Hypertension, Pulmonary | 2 | 2023 | 1592 | 0.180 |
Why?
|
TATA Box Binding Protein-Like Proteins | 1 | 2019 | 9 | 0.170 |
Why?
|
beta Karyopherins | 1 | 2019 | 46 | 0.170 |
Why?
|
Aged, 80 and over | 17 | 2021 | 58952 | 0.170 |
Why?
|
Interleukin-18 | 2 | 2019 | 250 | 0.170 |
Why?
|
COUP Transcription Factor II | 1 | 2019 | 18 | 0.170 |
Why?
|
Sarcoidosis, Pulmonary | 1 | 1999 | 45 | 0.170 |
Why?
|
Growth Differentiation Factor 15 | 1 | 2021 | 197 | 0.170 |
Why?
|
Pleural Diseases | 2 | 2017 | 137 | 0.160 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2011 | 4373 | 0.160 |
Why?
|
Scleroderma, Systemic | 1 | 2023 | 345 | 0.160 |
Why?
|
Pseudomonas Infections | 1 | 2023 | 621 | 0.160 |
Why?
|
Multivariate Analysis | 6 | 2019 | 12052 | 0.160 |
Why?
|
Pulmonary Alveolar Proteinosis | 1 | 2019 | 41 | 0.160 |
Why?
|
Genetic Markers | 3 | 2019 | 2599 | 0.150 |
Why?
|
Linear Models | 3 | 2019 | 5869 | 0.150 |
Why?
|
Incidental Findings | 2 | 2020 | 698 | 0.150 |
Why?
|
Common Variable Immunodeficiency | 1 | 2019 | 100 | 0.150 |
Why?
|
Cardiovascular Diseases | 2 | 2022 | 15521 | 0.150 |
Why?
|
Pulmonary Embolism | 2 | 2023 | 2571 | 0.150 |
Why?
|
Protein Kinase Inhibitors | 1 | 2014 | 5665 | 0.150 |
Why?
|
Genes, Immediate-Early | 1 | 1998 | 102 | 0.140 |
Why?
|
Lymphangioleiomyomatosis | 1 | 2019 | 204 | 0.140 |
Why?
|
Granuloma | 3 | 2019 | 326 | 0.140 |
Why?
|
Lung Transplantation | 3 | 2016 | 1307 | 0.140 |
Why?
|
Inflammasomes | 2 | 2012 | 526 | 0.140 |
Why?
|
Environmental Exposure | 4 | 2019 | 4479 | 0.140 |
Why?
|
Odds Ratio | 2 | 2021 | 9652 | 0.130 |
Why?
|
Early Diagnosis | 1 | 2021 | 1186 | 0.130 |
Why?
|
ROC Curve | 3 | 2022 | 3584 | 0.130 |
Why?
|
Administration, Inhalation | 3 | 2019 | 1159 | 0.130 |
Why?
|
Virus Activation | 1 | 1998 | 319 | 0.130 |
Why?
|
Acute Lung Injury | 3 | 2019 | 368 | 0.130 |
Why?
|
Fibrosis | 1 | 2023 | 2052 | 0.130 |
Why?
|
Gene Expression Regulation, Viral | 1 | 1998 | 433 | 0.130 |
Why?
|
Biopsy | 5 | 2019 | 6781 | 0.120 |
Why?
|
Follow-Up Studies | 7 | 2023 | 39127 | 0.120 |
Why?
|
Adult | 27 | 2024 | 221120 | 0.120 |
Why?
|
Dinoprostone | 1 | 1998 | 597 | 0.120 |
Why?
|
Axonemal Dyneins | 1 | 2014 | 25 | 0.120 |
Why?
|
Prognosis | 10 | 2024 | 29688 | 0.120 |
Why?
|
Lung Injury | 1 | 2019 | 422 | 0.120 |
Why?
|
CLOCK Proteins | 1 | 2014 | 86 | 0.110 |
Why?
|
Intensive Care Units | 4 | 2019 | 3744 | 0.110 |
Why?
|
Coronary Vessels | 1 | 2005 | 3111 | 0.110 |
Why?
|
Bronchial Provocation Tests | 2 | 2011 | 216 | 0.110 |
Why?
|
Antirheumatic Agents | 1 | 2023 | 1369 | 0.110 |
Why?
|
DNA | 2 | 2018 | 7189 | 0.110 |
Why?
|
Case-Control Studies | 7 | 2020 | 22174 | 0.110 |
Why?
|
Cytomegalovirus | 1 | 1998 | 750 | 0.110 |
Why?
|
Epidemiologic Studies | 2 | 2021 | 677 | 0.110 |
Why?
|
Cause of Death | 3 | 2020 | 3688 | 0.100 |
Why?
|
Leukocyte Count | 5 | 2014 | 1597 | 0.100 |
Why?
|
Risk Factors | 14 | 2023 | 74241 | 0.100 |
Why?
|
Leukocytes, Mononuclear | 1 | 2019 | 1838 | 0.100 |
Why?
|
Traction | 2 | 2023 | 111 | 0.100 |
Why?
|
Alleles | 4 | 2017 | 6857 | 0.100 |
Why?
|
Respiratory Tract Diseases | 1 | 2018 | 748 | 0.100 |
Why?
|
Early Detection of Cancer | 3 | 2023 | 3198 | 0.100 |
Why?
|
Retrospective Studies | 14 | 2024 | 80675 | 0.100 |
Why?
|
Collagen Diseases | 1 | 1992 | 39 | 0.100 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 1993 | 328 | 0.100 |
Why?
|
Bronchiolitis Obliterans | 1 | 2013 | 213 | 0.100 |
Why?
|
Transplantation | 1 | 2013 | 221 | 0.090 |
Why?
|
STAT6 Transcription Factor | 1 | 2011 | 196 | 0.090 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2021 | 1390 | 0.090 |
Why?
|
Child | 14 | 2010 | 80154 | 0.090 |
Why?
|
Oxygen | 1 | 2023 | 4228 | 0.090 |
Why?
|
Dyspnea | 1 | 2019 | 1347 | 0.090 |
Why?
|
Absorptiometry, Photon | 1 | 2017 | 1738 | 0.090 |
Why?
|
Cysts | 1 | 2015 | 680 | 0.090 |
Why?
|
Genetic Loci | 1 | 2019 | 2623 | 0.090 |
Why?
|
Thymus Gland | 1 | 2015 | 1243 | 0.090 |
Why?
|
Receptors, IgE | 1 | 2011 | 375 | 0.090 |
Why?
|
Hospital Mortality | 2 | 2014 | 5295 | 0.080 |
Why?
|
Severity of Illness Index | 8 | 2020 | 15841 | 0.080 |
Why?
|
Egg Proteins | 1 | 2009 | 57 | 0.080 |
Why?
|
Sex Factors | 4 | 2015 | 10553 | 0.080 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2009 | 41 | 0.080 |
Why?
|
Pedigree | 3 | 2021 | 4537 | 0.080 |
Why?
|
RNA, Messenger | 2 | 2014 | 12747 | 0.080 |
Why?
|
Genomics | 1 | 2024 | 5829 | 0.080 |
Why?
|
DNA, Mitochondrial | 1 | 2013 | 865 | 0.080 |
Why?
|
Heart Diseases | 1 | 2021 | 2795 | 0.080 |
Why?
|
Prospective Studies | 11 | 2024 | 54437 | 0.070 |
Why?
|
Vasculitis | 1 | 2012 | 522 | 0.070 |
Why?
|
Radiography, Thoracic | 2 | 2017 | 1302 | 0.070 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2019 | 3777 | 0.070 |
Why?
|
Respiration, Artificial | 2 | 2017 | 2631 | 0.070 |
Why?
|
Gene Expression Profiling | 3 | 2019 | 9417 | 0.070 |
Why?
|
Bronchospirometry | 1 | 2007 | 10 | 0.070 |
Why?
|
Sarcoidosis | 2 | 1986 | 537 | 0.070 |
Why?
|
Pneumonia | 2 | 2019 | 2142 | 0.070 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 12976 | 0.070 |
Why?
|
Tissue Donors | 1 | 2016 | 2335 | 0.070 |
Why?
|
Exercise Tolerance | 1 | 2012 | 838 | 0.070 |
Why?
|
Self Report | 1 | 2018 | 3727 | 0.070 |
Why?
|
Bone Marrow | 2 | 2015 | 2911 | 0.070 |
Why?
|
Respiratory Hypersensitivity | 1 | 2007 | 271 | 0.060 |
Why?
|
Genetic Linkage | 2 | 2008 | 2340 | 0.060 |
Why?
|
Biomedical Research | 1 | 2021 | 3434 | 0.060 |
Why?
|
Eosinophils | 2 | 2009 | 951 | 0.060 |
Why?
|
Air Pollution | 1 | 2019 | 2351 | 0.060 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2009 | 634 | 0.060 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2008 | 630 | 0.060 |
Why?
|
Mass Screening | 1 | 2021 | 5426 | 0.060 |
Why?
|
Fungi | 1 | 2007 | 337 | 0.060 |
Why?
|
Skin Tests | 1 | 2007 | 638 | 0.060 |
Why?
|
Inhalation Exposure | 1 | 2007 | 432 | 0.060 |
Why?
|
Health Status | 1 | 2018 | 4077 | 0.060 |
Why?
|
Inflammation | 1 | 2024 | 10759 | 0.060 |
Why?
|
Cardiac Surgical Procedures | 1 | 2019 | 3627 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4567 | 0.060 |
Why?
|
Critical Illness | 2 | 2014 | 2724 | 0.060 |
Why?
|
Graft Rejection | 2 | 2016 | 4481 | 0.060 |
Why?
|
Uridine Triphosphate | 1 | 2023 | 28 | 0.050 |
Why?
|
Drug Resistance | 1 | 2009 | 1594 | 0.050 |
Why?
|
Bronchodilator Agents | 1 | 2007 | 512 | 0.050 |
Why?
|
Circadian Rhythm | 1 | 2014 | 2569 | 0.050 |
Why?
|
Registries | 1 | 2019 | 8246 | 0.050 |
Why?
|
Family Health | 1 | 2007 | 1254 | 0.050 |
Why?
|
Comorbidity | 4 | 2022 | 10516 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2019 | 4251 | 0.050 |
Why?
|
Reproducibility of Results | 5 | 2023 | 20118 | 0.050 |
Why?
|
Caspase 1 | 2 | 2012 | 226 | 0.050 |
Why?
|
Linkage Disequilibrium | 3 | 2011 | 1994 | 0.050 |
Why?
|
Animals | 12 | 2021 | 168089 | 0.050 |
Why?
|
Treatment Outcome | 5 | 2019 | 64681 | 0.050 |
Why?
|
Body Mass Index | 2 | 2015 | 12952 | 0.050 |
Why?
|
Drug Synergism | 2 | 2012 | 1756 | 0.050 |
Why?
|
Biopsy, Needle | 2 | 2019 | 1624 | 0.050 |
Why?
|
Adolescent | 10 | 2017 | 88300 | 0.040 |
Why?
|
Molecular Epidemiology | 1 | 2022 | 470 | 0.040 |
Why?
|
Cross-Sectional Studies | 4 | 2021 | 26072 | 0.040 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2021 | 323 | 0.040 |
Why?
|
Bronchoalveolar Lavage Fluid | 2 | 2012 | 753 | 0.040 |
Why?
|
Liver | 1 | 2015 | 7512 | 0.040 |
Why?
|
Endothelial Cells | 1 | 2012 | 3552 | 0.040 |
Why?
|
Gene Expression | 2 | 2023 | 7571 | 0.040 |
Why?
|
Probability | 1 | 2024 | 2478 | 0.040 |
Why?
|
Bronchoalveolar Lavage | 1 | 2019 | 129 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2012 | 4935 | 0.040 |
Why?
|
Monocytes | 3 | 2022 | 2570 | 0.040 |
Why?
|
Boston | 2 | 2024 | 9327 | 0.040 |
Why?
|
Methacholine Chloride | 2 | 2009 | 220 | 0.040 |
Why?
|
Leukemia, Monocytic, Acute | 1 | 1998 | 58 | 0.040 |
Why?
|
Immunity, Cellular | 2 | 1986 | 1553 | 0.040 |
Why?
|
Occupations | 1 | 2020 | 517 | 0.040 |
Why?
|
Asbestosis | 1 | 2017 | 81 | 0.040 |
Why?
|
Carboxyhemoglobin | 1 | 2017 | 83 | 0.040 |
Why?
|
Sampling Studies | 1 | 2019 | 615 | 0.040 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2021 | 540 | 0.040 |
Why?
|
Oxidative Phosphorylation | 1 | 2019 | 495 | 0.040 |
Why?
|
International Classification of Diseases | 1 | 2023 | 915 | 0.040 |
Why?
|
Neoplasm Proteins | 1 | 2009 | 3594 | 0.040 |
Why?
|
Autoimmune Diseases | 1 | 2009 | 2244 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2019 | 15637 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2012 | 3245 | 0.030 |
Why?
|
Young Adult | 5 | 2017 | 59222 | 0.030 |
Why?
|
Diffusion of Innovation | 1 | 2021 | 730 | 0.030 |
Why?
|
MicroRNAs | 1 | 2012 | 3758 | 0.030 |
Why?
|
Ozone | 1 | 2019 | 482 | 0.030 |
Why?
|
Carbon | 1 | 2019 | 665 | 0.030 |
Why?
|
Pulmonary Surfactant-Associated Protein D | 1 | 2015 | 48 | 0.030 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2019 | 890 | 0.030 |
Why?
|
Electronic Health Records | 2 | 2023 | 4822 | 0.030 |
Why?
|
Incidence | 3 | 2023 | 21366 | 0.030 |
Why?
|
Sensitivity and Specificity | 3 | 2017 | 14675 | 0.030 |
Why?
|
T-Lymphocytes | 2 | 1986 | 10203 | 0.030 |
Why?
|
Matrix Metalloproteinase 7 | 1 | 2015 | 60 | 0.030 |
Why?
|
Vitamin D | 1 | 2009 | 3301 | 0.030 |
Why?
|
Cough | 1 | 2019 | 594 | 0.030 |
Why?
|
Pulmonary Artery | 1 | 2023 | 1929 | 0.030 |
Why?
|
Circadian Rhythm Signaling Peptides and Proteins | 1 | 2014 | 29 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15308 | 0.030 |
Why?
|
Blood Cell Count | 1 | 2015 | 396 | 0.030 |
Why?
|
Base Sequence | 2 | 2019 | 12404 | 0.030 |
Why?
|
Survival Analysis | 2 | 2020 | 10088 | 0.030 |
Why?
|
United States | 6 | 2021 | 72341 | 0.030 |
Why?
|
Internationality | 1 | 2019 | 999 | 0.030 |
Why?
|
Liver Function Tests | 1 | 2015 | 525 | 0.030 |
Why?
|
Freund's Adjuvant | 1 | 1993 | 144 | 0.030 |
Why?
|
Hospitalization | 3 | 2021 | 10707 | 0.030 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 1993 | 359 | 0.030 |
Why?
|
Bronchoscopy | 1 | 2019 | 909 | 0.030 |
Why?
|
Sepsis | 2 | 2019 | 2585 | 0.030 |
Why?
|
alpha Karyopherins | 1 | 2012 | 40 | 0.030 |
Why?
|
Granulocytes | 1 | 2014 | 550 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2009 | 7851 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2015 | 588 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2019 | 11067 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2019 | 1480 | 0.020 |
Why?
|
Pneumonectomy | 1 | 2019 | 1118 | 0.020 |
Why?
|
Endotoxins | 1 | 2014 | 520 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 2 | 2013 | 6486 | 0.020 |
Why?
|
Mycobacterium | 1 | 1993 | 251 | 0.020 |
Why?
|
Genetic Variation | 2 | 2021 | 6567 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 2019 | 1720 | 0.020 |
Why?
|
Area Under Curve | 1 | 2015 | 1636 | 0.020 |
Why?
|
Chemokines | 1 | 2015 | 956 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2020 | 2058 | 0.020 |
Why?
|
Endotoxemia | 1 | 2012 | 196 | 0.020 |
Why?
|
Macrophages | 1 | 1986 | 5755 | 0.020 |
Why?
|
Bleomycin | 1 | 2012 | 495 | 0.020 |
Why?
|
Spain | 1 | 2012 | 489 | 0.020 |
Why?
|
Observer Variation | 1 | 2017 | 2610 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 1993 | 1762 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2019 | 1743 | 0.020 |
Why?
|
B-Lymphocytes | 2 | 2019 | 4744 | 0.020 |
Why?
|
Up-Regulation | 1 | 2019 | 4111 | 0.020 |
Why?
|
Cyclophosphamide | 1 | 1976 | 2219 | 0.020 |
Why?
|
Lymphocytes | 2 | 2014 | 2603 | 0.020 |
Why?
|
Telomerase | 1 | 2015 | 741 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 1998 | 6125 | 0.020 |
Why?
|
E-Selectin | 1 | 2012 | 577 | 0.020 |
Why?
|
Transfection | 1 | 1998 | 5748 | 0.020 |
Why?
|
Community-Acquired Infections | 1 | 2014 | 469 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2020 | 2871 | 0.020 |
Why?
|
Double-Blind Method | 2 | 2017 | 12341 | 0.020 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2012 | 691 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2019 | 2092 | 0.020 |
Why?
|
Health Surveys | 1 | 2019 | 4037 | 0.020 |
Why?
|
Mice | 6 | 2014 | 81330 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2019 | 11855 | 0.020 |
Why?
|
Bronchoconstrictor Agents | 1 | 2009 | 77 | 0.020 |
Why?
|
Thoracic Surgery, Video-Assisted | 1 | 2012 | 285 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2012 | 748 | 0.020 |
Why?
|
Nedocromil | 1 | 2008 | 45 | 0.020 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2010 | 375 | 0.020 |
Why?
|
Risk Assessment | 3 | 2020 | 24022 | 0.020 |
Why?
|
Proteomics | 1 | 2022 | 3840 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2018 | 2420 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2020 | 3446 | 0.020 |
Why?
|
Time Factors | 2 | 2021 | 39957 | 0.020 |
Why?
|
Leukocytes | 2 | 2012 | 2025 | 0.020 |
Why?
|
Quality of Life | 2 | 2022 | 13367 | 0.020 |
Why?
|
Sex Ratio | 1 | 2008 | 107 | 0.020 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2009 | 418 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 3803 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2011 | 942 | 0.020 |
Why?
|
Bronchial Hyperreactivity | 1 | 2008 | 301 | 0.020 |
Why?
|
Databases, Factual | 1 | 2023 | 7965 | 0.020 |
Why?
|
Particulate Matter | 1 | 2019 | 2597 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2019 | 10756 | 0.020 |
Why?
|
Acute Disease | 1 | 2018 | 7226 | 0.020 |
Why?
|
Adaptive Immunity | 1 | 2012 | 724 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2576 | 0.020 |
Why?
|
Population Surveillance | 1 | 2017 | 2598 | 0.020 |
Why?
|
Autoantibodies | 1 | 2015 | 2119 | 0.020 |
Why?
|
HLA Antigens | 1 | 2011 | 1331 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2014 | 2329 | 0.020 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2009 | 790 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2009 | 1518 | 0.020 |
Why?
|
Chemotactic Factors | 1 | 1986 | 197 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2023 | 7407 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2010 | 1702 | 0.010 |
Why?
|
Radiography | 1 | 2016 | 6974 | 0.010 |
Why?
|
Walking | 1 | 2012 | 1194 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 2012 | 2199 | 0.010 |
Why?
|
Metabolomics | 1 | 2014 | 1658 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2013 | 4822 | 0.010 |
Why?
|
Genetics, Population | 1 | 2009 | 935 | 0.010 |
Why?
|
Exercise Test | 1 | 2012 | 2165 | 0.010 |
Why?
|
Massachusetts | 1 | 2017 | 8837 | 0.010 |
Why?
|
Anti-Asthmatic Agents | 1 | 2008 | 573 | 0.010 |
Why?
|
NF-kappa B | 1 | 2012 | 2475 | 0.010 |
Why?
|
Neutrophils | 1 | 1976 | 3763 | 0.010 |
Why?
|
Haplotypes | 1 | 2009 | 2715 | 0.010 |
Why?
|
Patient Selection | 1 | 2015 | 4246 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 1999 | 10218 | 0.010 |
Why?
|
Algorithms | 1 | 2023 | 14025 | 0.010 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2010 | 1249 | 0.010 |
Why?
|
Regression Analysis | 1 | 2012 | 6345 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 1999 | 7400 | 0.010 |
Why?
|
Interferons | 1 | 1986 | 702 | 0.010 |
Why?
|
Interleukin-1 | 1 | 1986 | 1250 | 0.010 |
Why?
|
Methylprednisolone | 1 | 1983 | 386 | 0.010 |
Why?
|
Exercise | 1 | 2018 | 5874 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2009 | 4107 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8663 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2008 | 4612 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2012 | 3044 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2012 | 9520 | 0.010 |
Why?
|
Critical Care | 1 | 2012 | 2696 | 0.010 |
Why?
|
Anti-Inflammatory Agents | 1 | 2009 | 1812 | 0.010 |
Why?
|
Interleukin-2 | 1 | 1986 | 1891 | 0.010 |
Why?
|
Therapeutic Irrigation | 1 | 1979 | 293 | 0.010 |
Why?
|
Mice, Mutant Strains | 1 | 1981 | 1751 | 0.010 |
Why?
|
Prednisone | 1 | 1983 | 1565 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2012 | 3885 | 0.010 |
Why?
|
Signal Transduction | 1 | 2020 | 23419 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2009 | 17598 | 0.010 |
Why?
|
Lymphokines | 1 | 1979 | 925 | 0.010 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 1976 | 317 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2016 | 6506 | 0.010 |
Why?
|
Leukopenia | 1 | 1976 | 213 | 0.010 |
Why?
|
Cell Line | 1 | 2009 | 15545 | 0.010 |
Why?
|
Genome, Human | 1 | 2008 | 4423 | 0.010 |
Why?
|
Guinea Pigs | 1 | 1976 | 1308 | 0.010 |
Why?
|
Research Design | 1 | 2010 | 6180 | 0.010 |
Why?
|
Disease Models, Animal | 2 | 2012 | 18222 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2012 | 22128 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 1979 | 2410 | 0.010 |
Why?
|
Mutation | 1 | 2015 | 30004 | 0.010 |
Why?
|
Neoplasms | 1 | 2016 | 22142 | 0.000 |
Why?
|
Child, Preschool | 1 | 2008 | 42225 | 0.000 |
Why?
|
Infusions, Parenteral | 1 | 1983 | 398 | 0.000 |
Why?
|
Administration, Oral | 1 | 1983 | 4015 | 0.000 |
Why?
|
Drug Therapy, Combination | 1 | 1983 | 6304 | 0.000 |
Why?
|